Stayble Therapeutics AB (publ) (STO:STABL)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.4150
-0.0045 (-1.07%)
Jul 2, 2025, 2:00 PM CET
42.12%
Market Cap 27.00M
Revenue (ttm) n/a
Net Income (ttm) -10.83M
Shares Out 64.36M
EPS (ttm) -0.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 123,439
Average Volume 605,711
Open 0.4090
Previous Close 0.4195
Day's Range 0.4025 - 0.4150
52-Week Range 0.2400 - 1.0500
Beta -0.08
RSI 45.75
Earnings Date Aug 15, 2025

About Stayble Therapeutics AB

Stayble Therapeutics AB (publ) develops injectable treatment for chronic pain triggered by disc degeneration. The company develops STA363, an injection into the disc that targets chronic low back and leg pain. Stayble Therapeutics AB (publ) was incorporated in 2015 and is based in Gothenburg, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2015
Employees 2
Stock Exchange Nasdaq Stockholm
Ticker Symbol STABL
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.